Balance and Posture in Adults With Cerebral Palsy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01585571|
Recruitment Status : Active, not recruiting
First Posted : April 26, 2012
Last Update Posted : February 10, 2017
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||80 participants|
|Official Title:||Observational Study of Balance and Posture in Adults With Cerebral Palsy|
|Study Start Date :||April 2012|
|Estimated Primary Completion Date :||December 2017|
|Estimated Study Completion Date :||December 2017|
50 individuals of typical development with no known neuromuscular issues.
Adults with CP
50 Individuals with a pediatric diagnosis of spastic, hemiplegic, diplegic or quadriplegic cerebral palsy.
- Center of Mass and Center of Pressure [ Time Frame: 4 hours ]The investigators will measure the movement of the subject's center of mass and center of pressure using a force platform while they are looking at different visual scenes and with slow force plate movements.
- Muscle activity [ Time Frame: 4 hours ]Muscle activity (recording using surface electrodes) will be performed while subjects are looking at different visual scenes and with slow force plate movements.
- Movement of the legs and trunk [ Time Frame: 4 hours ]Movement of the knee, ankle, hip and trunk (recorded using surface mounted markers) will be performed while subjects are looking at different visual scenes and with slow force plate movements.
- Visual dependence [ Time Frame: 1 hour ]Subjects will be seated in a chair, and asked to align a rotating rod to a vertical or horizontal position while receiving conflicting visual information ( a box placed around the rod in an off-center position)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01585571
|United States, Pennsylvania|
|Temple University, VEPO Laboratory|
|Philadelphia, Pennsylvania, United States, 19140|
|Principal Investigator:||Richard T Lauer, PhD||Temple University|